Vitiligo Drug Pipeline Analysis 2024: By Clinical Trial Phase: Late-Stage Products (Phase III and Phase IV), Mid-Stage Products (Phase II), Early-Stage Products (Phase I), Preclinical and Discovery Stage Products; By Drug Class: Corticosteroids, Calcineurin Inhibitors, Psoralens and UVA (PUVA), Immunomodulators, Janus Kinase (JAK) Inhibitors, Monoclonal Antibodies, and Melanocyte-stimulating Agents; By Product Type; By Treatment Type; Key Players

Datasheet

$ 1999.00